Advertisement
/ Customer
service
| About Us | Contact Us | Tell us what you think
| Jobs |
Shopping | Scandinavian
Dating | Archive
| Cookies
Advertisement
DiaGenic patent allowed in Canada
Thursday, 11 April 2013The Norwegian diagnostic company, DiaGenic announced that it has received notice of allowance for its Canadian family 2 patent application.
The allowed claims cover the use of a set of gene sequences in blood essential for the diagnosis of, among other diseases, Alzheimer’s disease and stages thereof. The patent when granted will be valid until 2023, the company said in a press release.
Scancomark.com Team
We
welcome your contribution. Did you find anything wrong with this
article? Do you want to contribute to our news network? Do have a news
tip or assist us with a correction